BOOTHBAY FUND MANAGEMENT, LLC
Position in ORMP — Oramed Pharmaceuticals Inc.
CIK 1549230
NEW YORK, NY
Position in ORMP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,783,248
+$740,814 QoQ
Shares Held
578,638
-3.7% QoQ
Ownership
1.39%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#7
of 84 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ORMP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BOOTHBAY FUND MANAGEMENT, LLC holds $665,103,201 across 158 Biotechnology names. ORMP ranks #54 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
465,787 | $87,232,589 | |
| 2 | ABVX |
Abivax S.A.
|
563,367 | $75,074,286 | |
| 3 | EXEL |
Exelixis, Inc.
|
804,095 | $43,750,808 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
534,163 | $31,050,895 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
692,825 | $26,812,327 | |
| 6 | CGEM |
Cullinan Therapeutics, Inc.
|
1,082,611 | $19,714,346 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
500,497 | $15,645,536 | |
| 8 | AVTX |
Avalo Therapeutics, Inc.
|
702,051 | $12,973,902 |
All Filings in ORMP
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,783,248 | 578,638 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $2,042,434 | 600,716 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,744,656 | 612,160 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,231,832 | 845,391 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,902,129 | 845,391 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,809,344 | 845,488 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,045,354 | 845,188 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,021,127 | 828,331 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $2,120,244 | 824,998 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,014,067 | 689,749 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $1,212,752 | 525,001 | Shares | Other | 2024-02-14 | |
| 2020-06-30 | $109,299 | 30,963 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $112,701 | 37,073 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||